Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

PIKfyve regulates pH homeostasis and tumor growth in pancreatic cancer

Award Number: F31CA298202
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 05/16/2025
PERIOD OF PERFORMANCE END DATE: 05/15/2028

Group Awards By:

View Award Description

PIKfyve regulates pH homeostasis and tumor growth in pancreatic cancer - PROJECT SUMMARY The current overall 5-year survival rate for pancreatic ductal adenocarcinoma (PDAC) is 13% and it is expected to become the second leading cause of cancer-related death. Given these poor statistics and the lack of effective therapies, novel approaches are needed in treating this disease. Targeting metabolic pathways specific to PDAC may be a relevant strategy in developing innovative treatments. Metabolic rewiring and nutrient scavenging, which support cancer cell proliferation and survival, contribute to disease aggressiveness in a tumor microenvironment that is poorly vascularized, nutrient-poor, and immunosuppressive. PIKfyve, a FYVE-finger containing phosphoinositide kinase, has been associated with membrane homeostasis and vesicle trafficking, where it is essential in driving endocytic maturation through the phosphorylation of phosphatidylinositol 3- phosphate (PI3P) to PI(3,5)P2 on endosome and endolysosome membranes. PIKfyve has been demonstrated to be a potential therapeutic target in multiple cancers including prostate, liver, and multiple myeloma but has not been comprehensively evaluated in PDAC. Pharmacological inhibition of PIKfyve is achieved via treatment with the small molecule apilimod, which has been shown to be cytotoxic in some cancer cells. This proposal evaluates PIKfyve as a therapeutic target in PDAC by assessing PIKfyve function on cell fitness and aggressiveness in vitro and evaluating the therapeutic effect of PIKfyve inhibition in vivo. My preliminary data suggest that inhibition and genetic knockdown of PIKfyve reduce PDAC cell proliferation and the effects are accompanied with the loss of pH homeostasis and blockade of macropinocytosis, a protein scavenging pathway active in PDAC. I will determine the mechanism by which PIKfyve activity contributes to cell fitness, metabolism, and aggressiveness. Moreover, the effect of PIKfyve on PDAC development will also be evaluated in vivo, expanding on preliminary studies in which PIKfyve inhibition reduced PDAC tumor size in an orthotopic syngeneic mouse model. The potential synergy of PIKfyve inhibitors with mechanism-specific drugs will also be evaluated in vivo. Combined, this study will provide mechanistic evidence and preclinical support for PIKfyve as a target in PDAC, potentially providing benefits to PDAC patients in the short-term since PIKfyve inhibition is currently being tested clinically for other indications.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $41,386 )
2026	2026	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE	10901 N TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Cancer Research Manpower	000	2	5/1/2026	NON-COMPETING CONTINUATION	$41,386
														Subtotal = $41,386

Issue Date FY: 2025 ( Subtotal = $40,810 )
2025	2025	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE	10901 N TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Cancer Research Manpower	000	1	5/6/2025	NEW	$40,246
2025	2025	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE	10901 N TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Cancer Research Manpower	002	1	5/28/2025	NEW	$0
2025	2025	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE	10901 N TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Cancer Research Manpower	001	1	5/28/2025	NEW	$564
														Subtotal = $40,810

Grand Total All Awards = $82,196

Top

All Categories

About

Search

Reports

Data Submission

Award Information

PIKfyve regulates pH homeostasis and tumor growth in pancreatic cancer

Award Number: F31CA298202

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 05/16/2025

PERIOD OF PERFORMANCE END DATE: 05/15/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer